SV Health Investors hits $265 million final close for first dedicated biotech fundraise

20 July 2020 – British Patient Capital provided a $65 million anchor investment for SV7 Impact Medicine Fund, which will aim to turn scientific breakthroughs into biotech companies producing high impact precision medicine drugs for poorly treated diseases. Read full article

British Patient Capital backs SV Health Investors Impact Medicine Fund

20 July 2020 – British Patient Capital has invested USD65 million in SV Health Investors’s USD265 million fund, SV7 Impact Medicine Fund (IMF), which is dedicated to investing in biotech companies. Read full article